Table 3.
Cause of death by risk group | No of events/Total No (%) | Radiotherapy versus surgery | ||||||
---|---|---|---|---|---|---|---|---|
Crude sHR (95% CI) | P value | Propensity score adjusted sHR (95% CI) | P value | Traditional covariate adjusted sHR (95% CI) | P value | |||
Radiotherapy | Surgery | |||||||
Risk group 1: | ||||||||
Prostate cancer | 32/3039 (1.1) | 44/10 003 (0.4) | 2.16 (1.37 to 3.42) | <0.001 | 1.91 (1.16 to 3.14) | 0.011 | 2.03 (1.22 to 3.40) | 0.007 |
Other causes | 223/3039 (7.3) | 412/10 003 (4.1) | 1.67 (1.42 to 1.97) | <0.001 | 1.26 (1.05 to 1.51) | 0.013 | 1.24 (1.04 to 1.48) | 0.019 |
Risk group 2: | ||||||||
Prostate cancer | 142/4030 (3.5) | 131/8125 (1.6) | 1.95 (1.53 to 2.47) | <0.001 | 1.77 (1.37 to 2.29) | <0.001 | 1.77 (1.36 to 2.30) | <0.001 |
Other causes | 376/4030 (9.3) | 365/8125 (4.5) | 1.94 (1.68 to 2.24) | <0.001 | 1.43 (1.23 to 1.68) | <0.001 | 1.40 (1.19 to 1.64) | <0.001 |
Risk group 3: | ||||||||
Prostate cancer | 418/5040 (8.3) | 118/2609 (4.5) | 1.69 (1.38 to 2.07) | <0.001 | 1.50 (1.19 to 1.88) | <0.001 | 1.63 (1.28 to 2.06) | <0.001 |
Other causes | 458/5040 (9.1) | 154/2609 (5.9) | 1.42 (1.18 to 1.70) | <0.001 | 1.20 (0.98 to 1.48) | 0.081 | 1.20 (0.97 to 1.48) | 0.091 |
Non-metastatic (risk groups 1-3): | ||||||||
Prostate cancer | 592/12 109 (4.9) | 293/20 737 (1.4) | 3.09 (2.69 to 3.56) | <0.001 | 1.76 (1.49 to 2.08) | <0.001 | 1.77 (1.49 to 2.09) | <0.001 |
Other causes | 1057/12 109 (8.7) | 931/20 737 (4.5) | 1.77 (1.62 to 1.93) | <0.001 | 1.32 (1.18 to 1.47) | <0.001 | 1.28 (1.16 to 1.42) | <0.001 |
Risk group 4: | ||||||||
Prostate cancer | 102/817 (12.5) | 43/389 (11.1) | 1.04 (0.73 to 1.48) | 0.835 | 0.76 (0.49 to 1.19) | 0.231 | 0.65 (0.40 to 1.05) | 0.081 |
Other causes | 65/817 (8.0) | 40/389 (10.3) | 0.71 (0.48 to 1.05) | 0.089 | 0.77 (0.45 to 1.34) | 0.362 | 0.61 (0.35 to 1.07) | 0.087 |